News
Media
Conferences
Events
Partners
Publications
Resources
Biomarker Consortium
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Jessica Lin, MD

Articles by Jessica Lin, MD

Jessica Lin, MD, associate professor, medicine, Harvard Medical School; attending physician, Center for Thoracic Cancers, Henri and Belinda Termeer Center for Targeted Therapies, Massachusetts General Hospital

Dr Lin on the Efficacy and Safety of Taletrectinib in ROS1 Fusion+ NSCLC

ByJessica Lin, MD

July 2nd 2024

Jessica Lin, MD, discusses key findings from the phase 2 TRUST-I trial in patients with ROS1 fusion–positive NSCLC.

Latest Updated Articles

Trending on OncLive

FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression

The OncFive: Top Oncology Articles for the Week of 1/25

HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts

FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma

Oncology Fellows Presents a New Drug Cheat Sheet for Fellows